SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia's blowout Q2 earnings and upbeat 70% FY2028 growth forecast have ignited a bullish retail frenzy, with traders celebrating the beat, brushing off bearish takes like Michael Burry's short position, and fueling an after-hours rally. Reports of a potential Hugging Face acquisition add further momentum, lifting the broader AI and memory complex.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

WEN is trending as retail traders react to reports that Trian has dropped its take-private bid, fueling intense debate over whether the drop is a bearish signal or a manipulation tactic to spark a short squeeze. Sentiment on Stocktwits remains 'extremely bullish' despite the news, with many seeing it as a buying opportunity. The broader context is a high short interest and large institutional holders, creating a volatile battle between bulls and bears.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending as traders dissect the fallout from Citadel's $4B+ liquidation of its Situational Awareness portfolio, seen as a major overhang finally clearing for AI/datacenter names. The conversation is split between those citing “massive selling pressure” from the unwind and bullish investors pointing to Nvidia's strong earnings and the $36B contract backlog as signs the selling is exhausted and a move higher is imminent.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is drawing intense debate as Michael Burry's continued buying and a historically low valuation clash with mounting concerns over weak U.S. consumer spending and tariff exposure, amplified by Dick's Sporting Goods' grim guidance and competitive pressure from brands like Alo. Bears see further downside amid sector-wide retail weakness, while bulls argue the stock is oversold and set for a sharp reversal.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Positive Phase III data from Akeso showing ivonescimab's overall survival benefit in biliary tract cancer has reignited bullish sentiment for Summit Therapeutics, with traders eyeing the Nov. 14 FDA decision and a flurry of insider buying as key catalysts. The broader thesis hinges on ivonescimab becoming a next-generation cancer immunotherapy, though a recent $500M offering keeps some bears cautious on dilution.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

CRM is trending after a strong Q2 earnings beat, raised guidance, and an expanded Anthropic partnership (Claudeforce) that sparked a double-digit after-hours surge. Retail sentiment turned bullish as traders see this as a decisive rebuttal to the 'SaaSpocalypse' AI-disruption narrative, reinforcing confidence in enterprise software's AI-driven growth.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

KURA is trending as the CEO's recent open-market purchase of 100,000 sharesworth roughly $1.11.2 millionsignals strong insider confidence, fueling retail speculation about a potential squeeze and acquisition interest. Community chatter highlights the buying as a key catalyst, reinforcing bullish sentiment around KOMZIFTI's launch and expectations of continued momentum.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

MRVL is surging into its upcoming earnings report, with traders fueling the move on the back of a massive Google custom-silicon deal and bullish analyst price-target hikes. The community is highly expectant of an AI-driven blowout, especially after Nvidia's strong results, leading to a mix of aggressive call buying and warnings about a potential post-earnings pullback.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXTI is trending due to extreme volatility tied to AI photonics demand and Indium Phosphide supply narratives, with traders closely watching upcoming Nvidia earnings as a potential catalyst. The stock is drawing intense debate between bulls pointing to Wall Street's big upside estimates and bears warning of a retail-driven bubble near historical highs.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is the center of attention as traders react to Nvidia's massive earnings beat and robust outlook, with the AI trade's circular financing concerns dominating the conversation. The community is split between bullish momentum plays on the Nasdaq and bearish fears of an AI bubble, making QQQ the key battleground for the broader market's direction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neurogene Reports Second Quarter 2026 Financial Results and Highlights Recent Updates

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced second quarter 2026 financial results and highlighted recent corporate updates. The second quarter and recent...

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Companys Board of Directors approved the grant of non-qualified stock...

Neurogene Inc. Announces Pricing of $125 Million Public Offering

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced the pricing of its previously announced public offering of 3,500,000 shares of its common stock at a public...

Neurogene Inc. Announces Proposed Public Offering

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that it has commenced a public offering of shares of its common stock or, in lieu of common stock to certain...

Neurogene Reports Positive Long-term Clinical Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced updated, positive data from its Phase 1/2 clinical trial evaluating NGN-401 gene therapy for the treatment of...

Neurogene Announces Successful Completion of Dosing in Embolden Registrational Trial of NGN-401 for Rett Syndrome

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced the successful completion of dosing in the Embolden registrational trial of NGN-401, an investigational gene...

Neurogene Reports First Quarter 2026 Financial Results and Highlights Recent Updates

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced first quarter...

Neurogene Highlights Data at ASGCT Meeting Supporting Therapeutic Rationale for ICV Delivery Method in CNS-targeted Gene Therapy

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, highlighted data at the...

Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.

Neurogene Inc

Why Did NGNE Stock Surge 25% In Pre-Market Today?

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$1.33	--	--	N/A
Q2 '26	-$1.42	-$1.53	-7.49%	MISSED
Q1 '26	-$1.30	-$1.39	-7.23%	MISSED
Q4 '25	-$1.25	-$1.12	10.60%	BEAT
Q3 '25	-$1.25	-$0.99	20.76%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings